BackTable Vascular & Interventional Ep. 589 Lung Cancer Tumor Boards: Multidisciplinary Approaches & Best Practices with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh, Dr. Alan Lee
Nov 14, 2025
Dr. Karen Reckamp, a thoracic oncologist, joins Dr. Alan Lee, a radiation oncologist, Dr. Scott Atay, a thoracic surgeon, and Dr. Scott Oh, an interventional pulmonologist, for a rich discussion on lung cancer management. They explore the dynamics of tumor boards, emphasizing collaborative decision-making and the benefits of hybrid meetings post-COVID. The panel dives into the significance of tissue diagnosis, mediastinal staging, and the evolving role of ablation therapy, highlighting challenges and strategies in treating early-stage and metastatic lung cancer.
AI Snips
Chapters
Transcript
Episode notes
Refer When Case Exceeds Your Expertise
- Know when to refer: if a case is high-risk or technically challenging, send it to thoracic specialists.
- Base referral decisions on patient risk, lesion location, and operator skill to ensure accurate staging and biopsy.
EBUS Has Largely Replaced Mediastinoscopy
- Surgical mediastinoscopy is now rare because high-quality EBUS largely replaces it.
- Surgeons reserve mediastinoscopy only for very high suspicion with negative EBUS or inadequate sampling.
Screening Uptake Hurt By Stigma
- Low lung screening uptake and stigma reduce early detection.
- Renaming programs as 'lung health checks' and public campaigns (NHS model) can improve participation.